Skip to search formSkip to main contentSkip to account menu

LY 2469298

Known as: LY-2469298, LY2469298 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

AME 133
ocaratuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Population Pharmacokinetics Study of a New Humanized Anti-CD20 Monoclonal Antibody AME-133v (LY2469298) in Patients with Previously Treated Follicular Lymphoma (FL)
Abstract 4982 Background: AME-133v is a humanized monoclonal antibody that was engineered to have increased affinity to CD20 and… 
2010
2010
Phase I Study of a New Humanized Anti-CD20 Monoclonal Antibody (LY2469298) in Japanese Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL) Pretreated with Rituximab-Containing Regimen
Abstract 3942 Background: Pts with FL in whom position 158 on the FcγRIIIa (CD16) gene is heterozygous for valine/phenylalanine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)